Data
Lookout
Search
Browse
Diseases
Sponsors
Pipeline Pulse
Weekly Report
Watchlist
Blog
Pricing
Sign In
Home
NCT07685600
Clinical Trial
Investigating the Effect of Itraconazole on the Pharmacokinetics of AZD4144 in Healthy Participants
Not Yet Recruiting
Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of the study is to assess the pharmacokinetics (PK) of AZD4144 when administered alone and in combination with itraconazole in healthy participants.
Trial Details
NCT Number
NCT07685600
Lead Sponsor
AstraZeneca
Conditions
Healthy
Enrollment
32 participants
Start Date
2026-07-30
Primary Completion
2026-10-28
(estimated)
Study Completion
2026-10-28
(estimated)
Updated on ClinicalTrials.gov
2026-07-06